An in vivo tumor treatment model of MEL was established by s.c. injecting SMMC-7721 cells into male BALB/c nude mice, which showed the significantly inhibited HIF-1α expression and tumor growth (Chen et al., 2019). The gene discussed is HIF1A; the disease is neoplasm.